TREATMENT OF EXPERIMENTAL INFECTIONS WITH AUREOMYCIN
1948; Wiley; Volume: 51; Issue: 2 Linguagem: Inglês
10.1111/j.1749-6632.1948.tb27271.x
ISSN1749-6632
AutoresMorton S. Bryer, Emanuel B. Schoenbach, Eleanor A. Bliss, Caroline A. Chandler,
Tópico(s)Antimicrobial Resistance in Staphylococcus
ResumoAnnals of the New York Academy of SciencesVolume 51, Issue 2 p. 254-266 TREATMENT OF EXPERIMENTAL INFECTIONS WITH AUREOMYCIN Morton S. Bryer, Morton S. Bryer Department of Preventive Medicine, The Johns Hopkins University School of Medicine, Baltimore, MarylandSearch for more papers by this authorEmanuel B. Schoenbach, Emanuel B. Schoenbach Department of Preventive Medicine, The Johns Hopkins University School of Medicine, Baltimore, MarylandSearch for more papers by this authorEleanor A. Bliss, Eleanor A. Bliss Department of Preventive Medicine, The Johns Hopkins University School of Medicine, Baltimore, MarylandSearch for more papers by this authorCaroline A. Chandler, Caroline A. Chandler Department of Preventive Medicine, The Johns Hopkins University School of Medicine, Baltimore, MarylandSearch for more papers by this author Morton S. Bryer, Morton S. Bryer Department of Preventive Medicine, The Johns Hopkins University School of Medicine, Baltimore, MarylandSearch for more papers by this authorEmanuel B. Schoenbach, Emanuel B. Schoenbach Department of Preventive Medicine, The Johns Hopkins University School of Medicine, Baltimore, MarylandSearch for more papers by this authorEleanor A. Bliss, Eleanor A. Bliss Department of Preventive Medicine, The Johns Hopkins University School of Medicine, Baltimore, MarylandSearch for more papers by this authorCaroline A. Chandler, Caroline A. Chandler Department of Preventive Medicine, The Johns Hopkins University School of Medicine, Baltimore, MarylandSearch for more papers by this author First published: November 1948 https://doi.org/10.1111/j.1749-6632.1948.tb27271.xCitations: 10 Aureomycin used in these experiments was supplied by the Lederle Laboratories Division, American Cyanamid Company. These investigations were supported by grants received from Abbott Laboratories; Eli Lilly and Company; Lederle Laboratories Division, American Cyanamid Company; Parke, Davis and Company; and the Upjohn Company. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Citing Literature Volume51, Issue2Aureomycin‐ A New AntibioticNovember 1948Pages 254-266 RelatedInformation
Referência(s)